Patient age in uveitis diagnoses and treatment plays a significant role, according to research published in American Journal of Ophthalmology.

Patients with JIA-associated uveitis who discontinued adalimumab had higher recurrence rates than those who continued the ...

Treatment Landscape The treatment of uveitis has evolved significantly, with a focus on reducing inflammation, managing symptoms, and preventing complications. Key treatment options include ...

Infliximab is more effective and safer than etanercept in the treatment of patients with noninfectious uveitis. Adalimumab is valid for severe uveitis, reducing efficacy for treatment of infliximab.

Background: Adalimumab taken every other week is an effective treatment in patients with chronic refractory uveitis. Patients who have a suboptimal response to this treatment may suffer from recurrent ...

"Lorem ipsum dolor sit amet, consectetur adipiscing elit, sed do eiusmod tempor incididunt ut labore et dolore magna aliqua. Ut enim ad minim veniam, quis nostrud exercitation ullamco laboris nisi ut ...

The case studies reported reversibility in all eyes affected with CME or uveitis either after discontinuation of PGAs alone or with medical treatment. A retrospective comparative case series by Chang ...

aFrancis I Proctor Foundation, University of California San Francisco, San Francisco, CA, USA bDepartment of Ophthalmology, University of California San Francisco, San Francisco, CA, USA cDepartment ...

A 56-year-old paramedic was admitted to hospital and treated for severe pneumonia. Shortly after initiating antibiotic treatment (including moxifloxacin), he developed bilaterally painful eyes and was ...